OTCMKTS:PURE

PURE Bioscience (PURE) Stock Price, News & Analysis

$0.08
0.00 (0.00%)
(As of 04/23/2024 ET)
Today's Range
$0.08
$0.08
50-Day Range
$0.07
$0.11
52-Week Range
$0.06
$0.17
Volume
1,159 shs
Average Volume
35,372 shs
Market Capitalization
$8.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PURE stock logo

About PURE Bioscience Stock (OTCMKTS:PURE)

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

PURE Stock Price History

PURE Stock News Headlines

PURE Bioscience, Inc. (PURE)
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Q4 2023 Arcus Biosciences Inc Earnings Call
PURE Bioscience Inc PURE
See More Headlines
Receive PURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/18/2024
Today
4/24/2024
Next Earnings (Estimated)
6/12/2024
Fiscal Year End
7/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous chemical products
Sub-Industry
N/A
Current Symbol
OTCMKTS:PURE
Employees
11
Year Founded
1992

Profitability

Net Income
$-3,960,000.00
Net Margins
-194.80%
Pretax Margin
-124.61%

Debt

Sales & Book Value

Annual Sales
$1.87 million

Miscellaneous

Free Float
65,145,000
Market Cap
$8.95 million
Optionable
Not Optionable
Beta
0.07

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Robert F. Bartlett (Age 79)
    President, CEO & Director
    Comp: $129.8k
  • Mr. Mark Stuart Elliott (Age 49)
    VP of Finance and Principal Financial & Accounting Officer
    Comp: $180k
  • Mr. Thomas Richard Myers (Age 71)
    Executive VP of Technology & Development and Director
    Comp: $200k
  • Mr. Jeff Kitchell
    VP of Operations & Corporate Secretary
  • Mr. Tim Steffensmeier
    Vice President of Sales & Marketing

PURE Stock Analysis - Frequently Asked Questions

How have PURE shares performed in 2024?

PURE Bioscience's stock was trading at $0.1297 at the start of the year. Since then, PURE shares have decreased by 38.3% and is now trading at $0.08.
View the best growth stocks for 2024 here
.

Are investors shorting PURE Bioscience?

PURE Bioscience saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 400 shares, a decrease of 97.7% from the February 29th total of 17,200 shares. Based on an average trading volume of 44,000 shares, the days-to-cover ratio is currently 0.0 days.
View PURE Bioscience's Short Interest
.

When is PURE Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our PURE earnings forecast
.

How were PURE Bioscience's earnings last quarter?

PURE Bioscience, Inc. (OTCMKTS:PURE) posted its quarterly earnings results on Monday, March, 18th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company earned $0.33 million during the quarter. PURE Bioscience had a negative net margin of 194.80% and a negative trailing twelve-month return on equity of 717.03%.

What other stocks do shareholders of PURE Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PURE Bioscience investors own include NVIDIA (NVDA), Boeing (BA), Overstock.com (OSTK), Pure Storage (PSTG), Riot Platforms (RIOT), Enphase Energy (ENPH), Mastercard (MA), Main Street Capital (MAIN), Twilio (TWLO) and

How do I buy shares of PURE Bioscience?

Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PURE) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners